Clinical Trial Detail

NCT ID NCT02466009
Title Regorafenib in Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors University of Rochester
Indications

colorectal adenocarcinoma

Therapies

Regorafenib

Age Groups: senior

No variant requirements are available.